CLIA Kit for Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1)
Référence USCN-SCA981Hu-96
Conditionnement : 96T
Marque : USCN
Contactez votre distributeur local :
Téléphone : +1 850 650 7790
CLIA Kit for Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1)
CHR-NA1; N-AChRA1; NAChRA1; ACHRA; ACHRD; CMS2A; FCCMS; SCCMS; Acetylcholine receptor subunit alpha; N-AChR-A1; Neuronal Acetylcholine Receptor Alpha 1,Muscle
- Product No.SCA981Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Test MethodDouble-antibody Sandwich
- Assay Length2h, 40min
- Detection Range68.6-50,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 29.5pg/mL.
- Sample TypeTissue homogenates and other biological fluids
- Download Instruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
-
Packages (Simulation) -
Packages (Simulation)
-
Results demonstration
-
ISO9001: 2008, ISO13485: 2003 Registered
Specificity of the CLIA Kit for Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1)
This assay has high sensitivity and excellent specificity for detection of Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1).
No significant cross-reactivity or interference between Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) and analogues was observed.
Precision of the CLIA Kit for Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1)
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Stability of the CLIA Kit for Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1)
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Assay procedure summary of the CLIA Kit for Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1)
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.
Test principle of the CLIA Kit for Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1)
The microplate provided in this kit has been pre-coated with an antibody specific to Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) level in the sample or standard.;